IgniteData

IgniteData is thrilled to partner with Advarra to transform how research sites manage clinical trial data. Together, we’re breaking down barriers between EHR, eSource, and EDC systems—simplifying data transfer, eliminating duplicate entry, and empowering sites to focus on what matters most: advancing research and improving patient outcomes. This partnership marks a major step toward smarter, faster, and more connected clinical trials. Read More: https://hubs.la/Q03SNwN90

Progress in clinical research is fundamentally linked to the quality and speed of data exchange. When sponsors, sites, and hospital systems are able to transmit data seamlessly, trials benefit from greater accuracy, reduced operational burden, and smoother progression from enrollment through analysis. Improved connectivity ultimately accelerates evidence generation and supports earlier access to promising therapies. Learn how Archer enables interoperable data flow between EHRs and EDCs https://lnkd.in/gsThRqdr

Oncology trials now generate data volumes and complexities that manual workflows can no longer support. Emerging evidence points to eSource-enabled EHR-to-EDC integration as a foundational shift—but widespread readiness gaps remain. Key pressures driving this transition include: -Expanding multimodal datasets -Rising regulatory and quality expectations -Increasing operational burden on research teams A new framework outlines how institutions can scale eSource through governance, readiness, and phased implementation. Great insights from Mats Sundgren—read the full analysis: https://hubs.la/Q03VR4s-0

Data duplication, manual entry, and transcription errors slow trials down. Advarra and IgniteData are changing that with a new integration that automates EHR and eSource data transfer and boosts accuracy by up to 99 percent. Learn how this partnership is transforming oncology trials. https://hubs.la/Q03TxnxM0

We’re thrilled to celebrate Mount Sinai Tisch Cancer Center’s leadership in innovation. Mount Sinai Health System has announced a groundbreaking real-time data integration initiative—powered by IgniteData’s Archer platform—that is transforming how clinical trial data moves between systems. By automating data transfer from Epic EHR directly into clinical trial databases, Mount Sinai is reducing manual data entry by up to 70%, accelerating accuracy, and giving research teams more time to focus on patients. This milestone, announced by Mount Sinai, represents a major step forward for the clinical research community—and we’re proud that IgniteData’s Archer platform is helping make it possible. Read Mount Sinai’s press release to learn how this collaboration is reshaping what’s possible in cancer research: https://hubs.la/Q03Q-dlp0

We’re thrilled to announce the final close of our oversubscribed $11M Series A, led by FCA Venture Partners, with major participation from the Labcorp Venture Fund and Epsilon. This milestone fuels our mission to transform how clinical data flows between sites and sponsors, reducing site burden, accelerating trial timelines, and unlocking the power of generative AI and intelligent data mapping through our flagship platform, Archer. A huge thank you to our new and returning investors, including SpringTide Ventures, Oncology Ventures, and leaders like Thomas Tarnowski, Marc Vangerven, and Andy Cooper, for their confidence in our vision to make clinical trials smarter, faster, and more connected than ever. Read More: https://hubs.ly/Q03RCBtW0